Ipilimumab (Yervoy™) belongs to a group of cancer drugs known as monoclonal antibodies. Monoclonal antibodies are sometimes called targeted therapies because they ‘target’ specific proteins (receptors) on the surface of cancer cells.
Ipilimumab is used to treat advanced melanoma. Melanoma is a type of skin cancer. It may also be used to treat other types of cancer as part of a research trial.
You will see your doctor regularly while you have this treatment so they can monitor its effects. This information should help you discuss any queries about your treatment and its side effects with your doctor or specialist nurse.